Rami Katkhuda
Stock Analyst at LifeSci Capital
(4.87)
# 345
Out of 4,651 analysts
328
Total ratings
55.2%
Success rate
30.9%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Rami Katkhuda
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ELDN Eledon Pharmaceuticals | Maintained: Buy | $8 | $3.54 | +125.99% | 42 | Aug 14, 2026 | |
| YARW Yarrow Bioscience | Maintained: Buy | $56 | $42.49 | +31.80% | 24 | Aug 13, 2026 | |
| ELOX Eloxx Pharmaceuticals | Maintained: Buy | $40 | $18.76 | +113.22% | 2 | Aug 12, 2026 | |
| MLYS Mineralys Therapeutics | Maintained: Buy | $54 | $25.64 | +110.61% | 25 | Aug 12, 2026 | |
| MAZE Maze Therapeutics | Maintained: Buy | $57 | $27.18 | +109.71% | 7 | Aug 12, 2026 | |
| VERA Vera Therapeutics | Maintained: Buy | $90 | $31.63 | +184.54% | 39 | Aug 11, 2026 | |
| MANE Veradermics | Maintained: Buy | $170 | $112.71 | +50.83% | 4 | Aug 11, 2026 | |
| MLTX MoonLake Immunotherapeutics | Maintained: Buy | $33 | $16.47 | +100.36% | 42 | Aug 10, 2026 | |
| JBIO Jade Biosciences | Maintained: Buy | $42 | $24.71 | +69.97% | 5 | Aug 10, 2026 | |
| VRDN Viridian Therapeutics | Maintained: Buy | $35 | $22.08 | +58.51% | 48 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $24 | $21.63 | +10.96% | 15 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $125 | $115.96 | +7.80% | 24 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $100 | $78.84 | +26.84% | 39 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 | $4.60 | +204.35% | 12 | Mar 31, 2026 |
Eledon Pharmaceuticals
Aug 14, 2026
Maintained: Buy
Price Target: $8
Current: $3.54
Upside: +125.99%
Yarrow Bioscience
Aug 13, 2026
Maintained: Buy
Price Target: $56
Current: $42.49
Upside: +31.80%
Eloxx Pharmaceuticals
Aug 12, 2026
Maintained: Buy
Price Target: $40
Current: $18.76
Upside: +113.22%
Mineralys Therapeutics
Aug 12, 2026
Maintained: Buy
Price Target: $54
Current: $25.64
Upside: +110.61%
Maze Therapeutics
Aug 12, 2026
Maintained: Buy
Price Target: $57
Current: $27.18
Upside: +109.71%
Vera Therapeutics
Aug 11, 2026
Maintained: Buy
Price Target: $90
Current: $31.63
Upside: +184.54%
Veradermics
Aug 11, 2026
Maintained: Buy
Price Target: $170
Current: $112.71
Upside: +50.83%
MoonLake Immunotherapeutics
Aug 10, 2026
Maintained: Buy
Price Target: $33
Current: $16.47
Upside: +100.36%
Jade Biosciences
Aug 10, 2026
Maintained: Buy
Price Target: $42
Current: $24.71
Upside: +69.97%
Viridian Therapeutics
Aug 6, 2026
Maintained: Buy
Price Target: $35
Current: $22.08
Upside: +58.51%
Aug 6, 2026
Maintained: Buy
Price Target: $24
Current: $21.63
Upside: +10.96%
Aug 4, 2026
Maintained: Buy
Price Target: $125
Current: $115.96
Upside: +7.80%
Jul 30, 2026
Maintained: Buy
Price Target: $100
Current: $78.84
Upside: +26.84%
Mar 31, 2026
Maintained: Buy
Price Target: $14
Current: $4.60
Upside: +204.35%